The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: A microdialysis study with freely moving rats

European Journal of Pharmacology

Volumn 601, Issue 1-3, 2008, Pages 94-98

  Mizoguchi, Naoko ^a   Saigusa, Tadashi ^a   Aono, Yuri ^a   Sekino, Reiko ^a   Takada, Koji ^a   Oi, Yoshiyuki ^a   Ueda, Koichiro ^a   Koshikawa, Noriaki ^a   Cools, Alexander R ^b  

^a NIHON UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

(Rat); Adrenoceptor; Dopamine; Microdialysis; Noradrenaline; Nucleus accumbens

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; DRUG VEHICLE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PROPRANOLOL; REBOXETINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOSE TIME EFFECT RELATION; DRUG INHIBITION; IN VIVO STUDY; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICRODIALYSIS; MORPHOLINES; NOREPINEPHRINE; NUCLEUS ACCUMBENS; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; TIME FACTORS;

EID: 56949084191     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.045     Document Type: Article

References (33)

1. Andén N.E., and Grabowska-Andén M. Formation of deaminated metabolites of dopamine in noradrenaline neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 324 (1983) 1-6
2. Aono Y., Saigusa T., Watanabe S., Iwakami T., Mizoguchi N., Ikeda H., Ishige K., Tomiyama K., Oi Y., Ueda K., Rausch W.-D., Waddington J.L., Ito Y., Koshikawa N., and Cools A.R. Role of alpha adrenoceptors in the nucleus accumbens in the control of accumbal noradrenaline efflux: a microdialysis study with freely moving rats. J. Neural Transm. 114 (2007) 1135-1142
3. A receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol. 580 (2008) 87-94
4. Benveniste H., Hansen A.J., and Ottosen N.S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 52 (1989) 1741-1750
5. Carboni E., Tanda G.L., Frau R., and Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55 (1990) 1067-1070
6. Carboni E., Silvagni A., Vacca C., and Di Chiara G. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. J. Neurochem. 96 (2006) 473-481
7. Cedarbaum J.M., and Aghajanian G.K. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 178 (1978) 1-16
8. Cools A.R., and Tuinstra T. Neurochemical evidence that mesolimbic noradrenaline directs mesolimbic dopamine, implying that noradrenaline, like dopamine, plays a key role in goal-directed and motivational behavior. In: Graybiel A.M., Delong M.R., and Kitai S.T. (Eds). The basal ganglia VI (advances in behavioral biology, volume 54) (2002), Plenum Publishers, New York 323-334
9. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G.S. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res. 806 (1998) 127-140
10. Fusa K., Saigusa T., Koshikawa N., and Cools A.R. Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens. Eur. J. Pharmacol. 448 (2002) 143-150
11. Fusa K., Takahashi I., Watanabe S., Aono Y., Ikeda H., Saigusa T., Nagase H., Suzuki T., Koshikawa N., and Cools A.R. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Neuroscience 130 (2005) 743-753
12. 2-adrenoceptors in the prefrontal cortex. Br. J. Pharmacol. 132 (2001) 183-188
13. Li M.Y., Yan Q.S., Coffey L.L., and Reith M.E. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 66 (1996) 559-568
14. Lindefors N., Amberg G., and Ungerstedt U. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods 22 (1989) 141-156
15. Linnér L., Endersz H., Ohman D., Bengtsson F., Schalling M., and Svensson T.H. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J. Pharmacol. Exp. Ther. 297 (2001) 540-546
16. 3H]dopamine release from rat nucleus accumbens slices: implications for research into depression. Neurochem. Res. 9 (1984) 1231-1238
17. Oades R.D., and Halliday G.M. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res. 434 (1987) 117-165
18. Okutsu H., Watanabe S., Takahashi I., Aono Y., Saigusa T., Koshikawa N., and Cools A.R. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively. Neuropsychopharmacology 31 (2006) 375-383
19. 1A receptors. Neurosci. Lett. 348 (2003) 171-174
20. Page M.E., and Lucki I. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology 27 (2002) 237-247
21. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. (2nd ed.) (1998), Academic Press, New York
22. Pozzi L., Invernizzi R., Cervo L., Vallebuona F., and Samanin R. Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem. 63 (1994) 195-200
23. Reisine T.D., Chesselet M.F., Lubetzki C., Chéramy A., and Glowinski J. A role for striatal beta-adrenergic receptors in the regulation of dopamine release. Brain Res. 241 (1982) 123-130
24. Reith M.E., Li M.Y., and Yan Q.S. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology (Berl.) 134 (1997) 309-317
25. Saigusa T., Takada K., Baker S.C., Kumar R., and Stephenson J.D. Dopamine efflux in the rat nucleus accumbens evoked by dopamine receptor stimulation in the entorhinal cortex is modulated by oestradiol and progesterone. Synapse 25 (1997) 37-43
26. Saigusa T., Tuinstra T., Koshikawa N., and Cools A.R. High and low responders to novelty effects of a catecholamine synthesis inhibitor on novelty-induced changes in behavior and release of accumbal dopamine. Neuroscience 88 (1999) 1153-1163
27. Saigusa T., Fusa K., Okutsu H., and Koshikawa N. Monitoring of extracellular dopamine levels in the dorsal striatum and the nucleus accumbens with 5-minute on-line microdialysis in freely moving rats. J. Oral Sci. 43 (2001) 129-134
28. B receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol. 581 (2008) 276-282
29. Tuinstra T., and Cools A.R. High and low responders to novelty: effects of adrenergic agents on the regulation of accumbal dopamine under challenged and non-challenged conditions. Neuroscience 99 (2000) 55-64
30. Valentini V., Frau R., and Di Chiara G. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J. Neurochem. 88 (2004) 917-927
31. Valentini V., Cacciapaglia F., Frau R., and Di Chiara G. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade. J. Neurochem. 98 (2006) 113-121
32. Verheij M.M., and Cools A.R. Twenty years of dopamine research: individual differences in the response of accumbal dopamine to environmental and pharmacological challenges. Eur. J. Pharmacol. 585 (2008) 228-244
33. Wong E.H., Sonders M.S., Amara S.G., Tinholt P.M., Piercey M.F., Hoffmann W.P., Hyslop D.K., Franklin S., Porsolt R.D., Bonsignori A., Carfagna N., and McArthur R.A. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol. Psychiatry 47 (2000) 818-829